4xnv: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
'''Unreleased structure'''
==The human P2Y1 receptor in complex with BPTU==
 
<StructureSection load='4xnv' size='340' side='right' caption='[[4xnv]], [[Resolution|resolution]] 2.20&Aring;' scene=''>
The entry 4xnv is ON HOLD
== Structural highlights ==
 
<table><tr><td colspan='2'>[[4xnv]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4XNV OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4XNV FirstGlance]. <br>
Authors: Wu, B., Zhao, Q., Zhang, D., Gao, Z., Jacobson, K., Han, G.W., Stevens, R.
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=1PE:PENTAETHYLENE+GLYCOL'>1PE</scene>, <scene name='pdbligand=BUR:1-[2-(2-TERT-BUTYLPHENOXY)PYRIDIN-3-YL]-3-[4-(TRIFLUOROMETHOXY)PHENYL]UREA'>BUR</scene>, <scene name='pdbligand=CLR:CHOLESTEROL'>CLR</scene>, <scene name='pdbligand=OLC:(2R)-2,3-DIHYDROXYPROPYL+(9Z)-OCTADEC-9-ENOATE'>OLC</scene>, <scene name='pdbligand=Y01:CHOLESTEROL+HEMISUCCINATE'>Y01</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
 
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4xnw|4xnw]]</td></tr>
Description: Human P2Y1 receptor
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4xnv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4xnv OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4xnv RCSB], [http://www.ebi.ac.uk/pdbsum/4xnv PDBsum]</span></td></tr>
[[Category: Unreleased Structures]]
</table>
== Function ==
[[http://www.uniprot.org/uniprot/P2RY1_HUMAN P2RY1_HUMAN]] Receptor for extracellular adenine nucleotides such as ATP and ADP. In platelets binding to ADP leads to mobilization of intracellular calcium ions via activation of phospholipase C, a change in platelet shape, and probably to platelet aggregation.<ref>PMID:9442040</ref> 
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Gao, Z]]
[[Category: Han, G W]]
[[Category: Jacobson, K]]
[[Category: Stevens, R]]
[[Category: Wu, B]]
[[Category: Wu, B]]
[[Category: Stevens, R]]
[[Category: Gao, Z]]
[[Category: Han, G.W]]
[[Category: Zhang, D]]
[[Category: Zhang, D]]
[[Category: Jacobson, K]]
[[Category: Zhao, Q]]
[[Category: Zhao, Q]]
[[Category: G protein coupled receptor]]
[[Category: Human p2y1 receptor]]
[[Category: Inhibitor complex]]
[[Category: Membrane protein]]
[[Category: Platelet activation]]
[[Category: Transport protein-inhibitor complex]]

Revision as of 13:22, 1 April 2015

The human P2Y1 receptor in complex with BPTU

4xnv, resolution 2.20Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA